#nuclear medicine
Text
Long term (10,000 years or more) nuclear storage; an interesting read, and I recommend it.
6 notes
·
View notes
Link
Carrier-free lutetium-177 has, up to now, been practically a monopoly of the Heinz Maier-Leibnitz Neutron Source, at Garching near Munich. In fact, I sat through a presentation on it when I visited there last year. Returning to the USA from that trip, I met an American in the airport who was returning from being treated with ¹⁷⁷Lu at the hospital at Garching!
1 note
·
View note
Text
Exploring Saudi Arabia and Middle East Radioisotope Production, Distribution, and Utilization
Saudi Arabia and Middle East Radioisotope production, distribution, and utilization constitute a multifaceted process that underpins various scientific, medical, and industrial applications. Understanding the intricacies of this cycle is crucial for maximizing the benefits of Saudi Arabia and Middle East Radioisotopes while ensuring safety and regulatory compliance. Let's embark on a journey to explore the key aspects of Saudi Arabia and Middle East Radioisotope production, distribution, and utilization, shedding light on their significance and impact across different sectors.
The production of Saudi Arabia and Middle East Radioisotopes typically begins with nuclear reactors or particle accelerators, where stable isotopes are bombarded with neutrons or charged particles to induce nuclear reactions. These reactions result in the formation of radioactive isotopes with specific properties and decay characteristics. Various production methods and target materials are employed to generate a diverse range of Saudi Arabia and Middle East Radioisotopes tailored to specific applications, from medical diagnostics and treatment to industrial testing and research.
Saudi Arabia and Middle East Radioisotopes undergo rigorous quality control and purification processes to ensure their safety, purity, and efficacy. This includes the removal of impurities and unwanted isotopes, as well as the verification of radiochemical purity and activity levels. Stringent quality assurance measures are implemented to meet regulatory requirements and standards, guaranteeing the reliability and consistency of Saudi Arabia and Middle East Radioisotope products for end-users.
The distribution of Saudi Arabia and Middle East Radioisotopes involves intricate logistics and regulatory considerations to facilitate their safe and efficient transport from production facilities to end-users worldwide. Specialized packaging, handling, and shipping procedures are implemented to minimize radiation exposure and prevent contamination during transit. Strict regulatory frameworks govern the transportation of radioactive materials, with comprehensive safeguards and security measures in place to mitigate potential risks and ensure compliance with international regulations.
Get More Insights On This Topic: Saudi Arabia and Middle East Radioisotopes
#Saudi Arabia#Middle East#Radioisotope#Nuclear Medicine#Scientific Research#Healthcare#Industry#Technology
0 notes
Text
youtube
Have you ever wondered what PET scan images show? In this short video, we get an inside view of a PET scan overlayed with a CT scan.
#pet scan#positron emission tomography#nuclear medicine#radiology#diagnostic imaging#medical#Youtube
0 notes
Text
QU’EST CE QU’UNE SCINTIGRAPHIE À L’OCTREOSCAN ?
_
Cet examen est réalisé pour diagnostiquer certaines tumeurs neuro-endocrines bien différenciées et de préciser leur extension.
Elles sont situées le plus souvent au niveau du tube digestif ou du pancréas et sécrètent des hormones spécifiques.
___________________________________________________
Comment prendre OCTREOSCAN :
_
Posologie
Adulte et population âgée
Pour la tomoscintigraphie monophotonique (TEMP), l'activité à injecter dépend de l'équipement dont on dispose. En général pour un adulte de 70 kg, une activité de 110 à 220 MBq administrée en une seule injection intraveineuse est suffisante. D'autres activités peuvent être injectées si justifié.
1 note
·
View note
Text
Nuclear Medicine Learning Resources
Learning
Dartmouth Nuclear Medicine Papers
Nuclear Medicine on Internet
AUR Radiology Resident Core Curriculum Lecture Series | Nuclear Imaging
UW Nuclear Medicine Lecture Notes
Cases
NUC RAD Share | NM Cases
WUSTL MIR | Nuclear Medicine Teaching Files
UW Neuroradiology Teaching Files
1 note
·
View note
Text
Global Nuclear Medicine Therapeutics Market: Pioneering Healthcare Solutions
A pharmaceutical composition including radioactive elements is known as therapeutic nuclear medicine. In comparison to X-rays and other external radiation imaging technologies, therapeutic nuclear medicines are widely employed as an effective and safer alternative for cancer patients.
Market Size & Growth Rate:
The nuclear medicine therapeutics market was valued at USD 1 billion in 2021 and is expected to reach USD 1.8 billion by 2027, exhibiting a CAGR of 9.6% during the forecast period 2022-2027. The growth could be attributed to the return of demand to pre-pandemic levels, increasing authorization of novel & innovative medicines, extensive research, disease prevalence, and immunotherapies.
Market Dynamics:
According to the oncidium foundation, nuclear-therapy accounted for 20% of the global nuclear medicine market in 2019 and is expected to reach 70% by 2030. Nuclear therapeutic is majorly used for the treatment & diagnosis of Cardiovascular Disease (CVD) and cancers. According to WHO-2021, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. The prevalence of these markets has promoted several market players and stakeholders to focus on expanding the overall application of radio-therapeutics. With the expanding application segments of nucleo-emitters, their demand and anticipated rising during the forecast period. It indicates to market players for growth of the nuclear medicine therapeutics market. In addition, various R&D activities in the business space are expected to stimulate the demand for therapeutic nuclear medicine through 2029. For instance,
Click here for full report:
https://www.pharmanucleus.com/reports/nuclear-medicine-therapeutics
Click here for Free Sample:
https://www.pharmanucleus.com/request-sample/1165
Based on the radionuclide therapeutic type, the beta emitters segment grow at a considerable pace during the forecast period. These beta particles like Samarium-153 (SM-153), Iodine-131 (I-131), and Lutetium-177 (LU-177) are known to be lighter than alpha particles like Radium-224 (RA-224), Radium-223 (RA-223) and can penetrate the skin easily
Get more details on this report - Request Free Sample
According to precedence research, by application, the oncology segment accounted major market share of around 40% in 2021 followed by cardiology.
Market Drivers:
Click here for full report:
https://www.pharmanucleus.com/reports/nuclear-medicine-therapeutics
The market players are focusing on various research developments, product launches, and acquisitions that are anticipated to increase the market growth. For instance,
Challenges:
#nuclear medicine#therapeutics#healthcare solutions#radiopharmaceuticals#medical innovation#patient care#nuclear medicine trends#advanced treatments#healthcare breakthroughs#cutting-edge therapies#global market insights
0 notes
Text
The Presence of Nuclear Energy in Our Daily Lives: Exploring the Link Between Food and Radioactive Isotopes
Introduction
Nuclear energy is a controversial topic, and opinions on its use vary widely. However, one fact that is often overlooked is that nuclear energy is all around us, even in the food we eat. This article will explore this claim in detail, covering all aspects from various angles.
What is Nuclear Energy?
Nuclear energy is the energy released from the nucleus of an atom through nuclear…
View On WordPress
1 note
·
View note
Text
Mediray History | Vial shield, Syringe shield, Nuclear medicine
Medi-RayTM produced specialized packaging, vial shields, syringe shields, shielded storage and waste containers and shielded, diagnostic radioisotope preparation kits.
Read more....https://mediray.com/history/
#vial shield#syringe shield#nuclear medicine#shielded storage#waste containers and shielded#applications of radioisotopes#diagnostic radiology#therapeutic radiology
0 notes
Photo
"Uranian" should only used for nuclear medicine! If every country on Earth has nuclear power stations, The World would run out of uranium in about 30 years or so THEN WHAT??? A future's thought! Is Science clever enough to create "artificial uranium" ... Misha
1 note
·
View note
Text
If you are looking for a nuclear medicine doctor, Sohana Hospital is the right choice for you. People believe in us and rely on our services as we have the best nuclear medicine doctors in North India.
0 notes
Link
Since the discovery of the means to artificially synthesize radioisotopes (early 1930s), they were almost immediately adopted for healthcare applications, by the mid-1940s. Presently, a variety of diagnostic and therapeutic techniques are based on the use of such substances, commonly referred to as radiopharmaceuticals. Despite their inherent toxicity, nuclear medicine is considered an important part of modern healthcare, with applications spanning across a number of therapeutic areas, including infectious diseases, immunological disorders, gastroenteric disease, cardiological disorders, oncological disorders, neurological disorders, and even certain psychiatric conditions. According to an article published by World Nuclear Association in May 2020, more than 10,000 hospitals worldwide claim to be using radioisotopes for various medical procedures; interestingly, of the aforementioned applications, 90% were reported to be related to disease diagnosis Typically, diagnostic tests, involving radiopharmaceuticals, are performed using highly specialized imaging solutions, such as single photon emission computed tomography (SPECT) and positron emission tomography (PET). It is worth highlighting that around 40 million diagnostic procedures, involving the use of the radioisotope Tc-99m alone, are conducted worldwide annually. Further, the introduction of the concept of theranostics, which involves the use of a single active ingredient for both diagnostic and therapeutic purposes, has opened up a new dimension of applications for nuclear medicine.
1 note
·
View note
Text
Nuclear Medicine and PET CT Scan
Omega Bannu Hospital is the one of the best Nuclear Medicine and PET CT Scan Center in Warangal, Karimnagar, Khammam. Book PET CT scan at the low price in Warangal
NUCLEAR MEDICINE TECHNOLOGYIn the department of Nuclear Medicine at Omega Bannu Hospital, the team of specialists diagnose and treat cancer by administering radioactive substances. The doctors use several radionuclides, which are administered intravenously, orally, or inhaled. Radionuclides are derivatives of radioactive elements such as gallium, technetium, xenon, thallium, and iodine.
While blood tests are conducted, medications are modified, and therapy is prepared, it might take up to a month before you can start therapy. We offer outpatient treatment which continues on-site for up to eight hours each time.
The treatments prescribed by our team take into account many factors and are adjusted over time based on individual circumstances. As part of the infusion treatments, one might be asked to have a SPECT scan, which measures how much nuclear medicine therapy is stuck to the cancer cells and how quickly it is leaving the body. Our oncologists make therapy decisions based on this information so that they can cure cancer while avoiding side effects. We encourage our patients to follow up with us post-therapy, including more blood tests and scans that may be necessary.Treatments in Nuclear Medicine:Radioimmunotherapy:
Our doctors recommend Radioimmunotherapy if one has Non-Hodgkin’s lymphoma that doesn’t respond to chemotherapy. Also known as RIT, this treatment combines radiation therapy with immunotherapy
Radioactive Iodine Therapy:
Our doctors recommend Radioactive Iodine Therapy if one’s thyroid gland absorbs almost all the iodine taken in. Radioactive iodine therapy prevents other parts of your body from being damaged without damaging your cells. In some cases, it destroys other cancer cells of the body where thyroid cancer has spread.Brachytherapy:
In most cases, brachytherapy is recommended by our doctors as it is more targeted, causes fewer side effects, and is shorter than conventional radiation therapy.
Y 90 Radioembolization:
This treatment is typically used to treat hepatocellular carcinomas and liver cancers.
0 notes
Text
The nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals
Roots Analysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030”
The report provides a detailed study on the current market landscape and future potential of the companies having the capabilities to manufacture radiopharmaceuticals. In addition, the study features an in-depth analysis, highlighting the capabilities of a diverse set of industry stakeholders. Amongst other elements, the report features the following:
§ A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals.
§ An insightful four-dimensional comparison of the radiopharmaceutical manufacturers.
§ Tabulated profiles of key industry players based in North America, Europe and Asia-Pacific (shortlisted based on the company size of the players).
§ An analysis of recent partnerships and collaborations inked in this domain since 2017.
§ A detailed discussion on the supply chain model of medical isotope Mo-99 (Tc-99m).
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
§ Target Therapeutic Area
§ Cardiology
§ Neurology
§ Oncology
§ Thyroid
§ Others
Application Area
§ Diagnostic
§ Therapeutic
§ Type of Diagnostic Radiopharmaceuticals
§ PET
§ SPECT
§ Type of Therapeutic Radiopharmaceuticals
§ Alpha Emitters
§ Beta Emitters
§ Others
§ Purpose of Production
§ In-House
§ Outsourcing
Key Geographical Region
§ North America
§ Europe
§ Asia-Pacific and the Rest of the World
Transcripts of interviews held with the following senior level representatives of stakeholder companies
§ J James Davis, Vice President Quality / R&D, Shertech Laboratories
§ Andreas Fotopoulos, Professor of Nuclear Medicine, University of Ioannina Medical School
§ Jan Pruim, Professor of Medical Imaging / Nuclear Medicine Physician, University Medical Center of Groningen
§ Michael van Dam, Professor, Crump Institute for Molecular Imaging, Molecular & Medical Pharmacology
§ Anonymous, ITM Isotopen Technologien München
Key companies covered in the report
§ Advanced Accelerator Applications
§ Belgian Nuclear Research Center (SCK•CEN)
§ Cardinal Health
§ China Isotope & Radiation Corporation
§ Curium Pharma
§ DuChemBio
§ Eckert & Ziegler
§ Eczacibasi-Monrol
§ GE Healthcare
§ Jubilant DraxImage
§ Lantheus Medical Imaging
§ Nihon Medi-Physics
§ Nordion
§ PETNET Solutions
§ SinoTau Pharmaceuticals
§ SOFIE
For more information please click on the following link:
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
Other Recent Offerings
1. High Energy Chemistry / Hazardous Chemistry-based API Manufacturing Services Market: Focus on High Temperature, Low Temperature / Cryogenic, High Pressure and Low Pressure Chemistries, 2020-2030
2. Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030
3. China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030
4. Continuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
0 notes
Last Seen Blogs
s0ulfulsapph1c
Birds Are All Gay
xabier99
Sin título
magicpony45
Magic
futuristicrainbowtree
💙Kyle GarnetYT💙
aweddle83
AngelaWeddle’sArt